Estados Unidos · Bolsa y Finanzas · Yahoo Finance

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

Publicado por Yahoo Finance · Estados Unidos hace 11 h

REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, is added to the alliance, along with a long-acting IL-4xIL-13 bispecific and…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

También te puede interesar

Regeneron drug said to cut muscle loss when combined with Novo's semaglutide

Bitcoin think tank questions MSCI’s ‘invisible committee’ over Strategy, Metaplanet rule

South Korean President Lee pushes back on Alaska LNG project after Trump touts Seoul's participation

Brent Tumbles to $96 as Gulf Oil Flows Bounce Back

Dogecoin gets DeFi testnet as DogeOS bets miners will eventually secure its apps

I was lonely and working 15-hour days in the US. Moving to the Philippines gave me a community.

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

Compartir

También te puede interesar

Regeneron drug said to cut muscle loss when combined with Novo's semaglutide

Bitcoin think tank questions MSCI’s ‘invisible committee’ over Strategy, Metaplanet rule

South Korean President Lee pushes back on Alaska LNG project after Trump touts Seoul's participation

Brent Tumbles to $96 as Gulf Oil Flows Bounce Back

Dogecoin gets DeFi testnet as DogeOS bets miners will eventually secure its apps

I was lonely and working 15-hour days in the US. Moving to the Philippines gave me a community.